TY - JOUR
T1 - Effects of 5 HIV protease inhibitors on vasomotor function and superoxide anion production in porcine coronary arteries
AU - Chai, Hong
AU - Yang, Hui
AU - Yan, Shaoyu
AU - Li, Min
AU - Lin, Peter H.
AU - Lumsden, Alan B.
AU - Yao, Qizhi
AU - Chen, Changyi
N1 - Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2005/9/1
Y1 - 2005/9/1
N2 - HIV protease inhibitors (PIs) have been implicated to cause cardiovascular complications. Previous studies demonstrated that the PI ritonavir (RTV) caused endothelial dysfunction in porcine arteries. This study investigated and compared the effects of 5 commonly used PIs on vasomotor function, endothelial nitric oxide synthase (eNOS) expression, and oxidative stress in porcine coronary arteries. Vessel rings were incubated with 15 μM of RTV, amprenavir (APV), saquinavir (SQV), indinavir (IDV), or nelfinavir (NFV) for 24 hours. Vasomotor function was studied using a myograph system. The contractility of the rings was significantly reduced for RTV and SQV. In response to bradykinin at 10-5 M, the endothelium-dependent relaxation was significantly reduced for RTV, APV, and SQV. The eNOS mRNA levels were significantly reduced for RTV, APV, and SQV. Furthermore, the superoxide anion (O2 -) levels of the vessels were significantly increased for RTV and APV. It was found that nitric oxide production was decreased, whereas the level of nitrotyrosine proteins was increased in RTV-treated vessels. Furthermore, antioxidant seleno-L-methionine (SeMet) reversed RTV-induced O2 - production and vasomotor dysfunction. Thus, the HIV PIs RTV, APV, and SQV at 15 μM have more potent in vitro effects on vasomotor dysfunction, eNOS downregulation, and O2
- production than IDV and NFV. The antioxidant SeMet can block these adverse effects of RTV. The results suggest that antioxidant therapy may have applications for controlling PI-associated cardiovascular complications.
AB - HIV protease inhibitors (PIs) have been implicated to cause cardiovascular complications. Previous studies demonstrated that the PI ritonavir (RTV) caused endothelial dysfunction in porcine arteries. This study investigated and compared the effects of 5 commonly used PIs on vasomotor function, endothelial nitric oxide synthase (eNOS) expression, and oxidative stress in porcine coronary arteries. Vessel rings were incubated with 15 μM of RTV, amprenavir (APV), saquinavir (SQV), indinavir (IDV), or nelfinavir (NFV) for 24 hours. Vasomotor function was studied using a myograph system. The contractility of the rings was significantly reduced for RTV and SQV. In response to bradykinin at 10-5 M, the endothelium-dependent relaxation was significantly reduced for RTV, APV, and SQV. The eNOS mRNA levels were significantly reduced for RTV, APV, and SQV. Furthermore, the superoxide anion (O2 -) levels of the vessels were significantly increased for RTV and APV. It was found that nitric oxide production was decreased, whereas the level of nitrotyrosine proteins was increased in RTV-treated vessels. Furthermore, antioxidant seleno-L-methionine (SeMet) reversed RTV-induced O2 - production and vasomotor dysfunction. Thus, the HIV PIs RTV, APV, and SQV at 15 μM have more potent in vitro effects on vasomotor dysfunction, eNOS downregulation, and O2
- production than IDV and NFV. The antioxidant SeMet can block these adverse effects of RTV. The results suggest that antioxidant therapy may have applications for controlling PI-associated cardiovascular complications.
KW - Antioxidant
KW - Coronary artery
KW - HIV protease inhibitor
KW - Nitric oxide synthase
KW - Oxidative stress
KW - Superoxide anion
KW - Vasomotor
UR - http://www.scopus.com/inward/record.url?scp=24144432810&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=24144432810&partnerID=8YFLogxK
U2 - 10.1097/01.qai.0000172368.05327.7b
DO - 10.1097/01.qai.0000172368.05327.7b
M3 - Article
C2 - 16123675
AN - SCOPUS:24144432810
SN - 1525-4135
VL - 40
SP - 12
EP - 19
JO - Journal of Acquired Immune Deficiency Syndromes
JF - Journal of Acquired Immune Deficiency Syndromes
IS - 1
ER -